跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 535,611 条关于
“Schizophrenia Society of Canada”
全部
535,611
临床试验
486,904
药物
4,488
机构
3,430
资讯
40,789
去年
AbbVie's VRAYLAR Achieves Full Provincial Coverage in Canada with Alberta Reimbursement Approval
去年
Viatris Launches First Clozapine Orally Disintegrating Tablet in Canada for Treatment-Resistant Schizophrenia
去年
Pharmaceutical R&D Highlights of 2024: GLP-1s, CRISPR, and More
去年
Key Highlights from the American Society of Hematology Meeting and Regulatory Updates
上个月
Society of Hematologic Oncology Launches Second Educational Podcast, SOHO Spotlight, on Hematologic Malignancy Management
去年
Alzamend Neuro to Present Non-Clinical Data on AL001 at Society of Toxicology 2025
6个月前
Spinogenix Completes Enrollment in Phase 2 Trial of Tazbentetol for Schizophrenia Treatment
去年
Tabelecleucel Shows Sustained Efficacy in EBV+ PTLD, FDA Decision Expected in January 2025
2年前
Novel Therapies for Wet AMD Target Reduced Injection Burden and Broader VEGF Inhibition
去年
Endo Presents Collagenase Clostridium Histolyticum (CCH) Data for Plantar Fibromatosis at ASPS Conference
第 1 页，共 4079 页
上一页
下一页
